| Date | Research Question / Title | Unique ID | Research Team |
|---|---|---|---|
| April 1, 2021 | What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations? | EOC210302 ESR | EOC |
| March 4, 2022 | What is the safety/efficacy of the Novavax vaccine? | EOC220302 ESR | EOC |
